TZUP vs. OPRX, TSSI, TRAK, SHAP, PAYS, YMT, EGHT, III, AHG, and TRVG
Should you be buying Thumzup Media stock or one of its competitors? The main competitors of Thumzup Media include OptimizeRx (OPRX), TSS (TSSI), ReposiTrak (TRAK), Spree Acquisition Corp. 1 (SHAP), Paysign (PAYS), Yimutian (YMT), 8X8 (EGHT), Information Services Group (III), Akso Health Group (AHG), and Trivago N.V. ADS (TRVG). These companies are all part of the "business services" industry.
Thumzup Media vs. Its Competitors
OptimizeRx (NASDAQ:OPRX) and Thumzup Media (NASDAQ:TZUP) are both small-cap business services companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, dividends, institutional ownership, risk, media sentiment, earnings, profitability and analyst recommendations.
Thumzup Media has lower revenue, but higher earnings than OptimizeRx. OptimizeRx is trading at a lower price-to-earnings ratio than Thumzup Media, indicating that it is currently the more affordable of the two stocks.
Thumzup Media has a net margin of 0.00% compared to OptimizeRx's net margin of -9.42%. OptimizeRx's return on equity of 4.50% beat Thumzup Media's return on equity.
76.5% of OptimizeRx shares are held by institutional investors. 5.6% of OptimizeRx shares are held by company insiders. Comparatively, 43.5% of Thumzup Media shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
In the previous week, Thumzup Media had 3 more articles in the media than OptimizeRx. MarketBeat recorded 8 mentions for Thumzup Media and 5 mentions for OptimizeRx. OptimizeRx's average media sentiment score of 1.48 beat Thumzup Media's score of 0.76 indicating that OptimizeRx is being referred to more favorably in the media.
OptimizeRx currently has a consensus target price of $11.81, suggesting a potential downside of 33.60%. Given OptimizeRx's stronger consensus rating and higher probable upside, analysts plainly believe OptimizeRx is more favorable than Thumzup Media.
Summary
OptimizeRx beats Thumzup Media on 10 of the 15 factors compared between the two stocks.
Get Thumzup Media News Delivered to You Automatically
Sign up to receive the latest news and ratings for TZUP and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding TZUP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Thumzup Media Competitors List
Related Companies and Tools
This page (NASDAQ:TZUP) was last updated on 9/9/2025 by MarketBeat.com Staff
